Navigation Links
Patient Negligence - Significant Problem In The Early Detection Of Breast Cancer

Breast cancer is the most common type of cancer among women. Despite the awareness programmes and the massive screening strategies, it has not possible to eliminate the fear associated with the disease. Mammography is one of the routine tests // used in the early identification of the disease.

However, a new study finds the number of women getting routine screening mammography may be less than previously reported. As many as one in three women have never had a mammogram or have not had one in more than two years. Furthermore, many women who have had one or two mammograms failed to return for regular screenings.

While screening mammography has been credited with significant improvements in breast cancer outcomes, the success of campaigns to increase screening use have not shown consistent improvements.

In New Hampshire studies assessing use demonstrate that overall use by women 50 years old and older range from 65-82 percent and depend on age. However, these studies rely on self-reporting surveys prone to poor patient recall or single community healthcare facility use.

The researchers found 36 percent of women 40 and over in New Hampshire had either never had a mammogram or had not had one in over 27 months. Older women over 80 years old were more likely than younger women to not receive screening.

Among those women who had received screening in their lifetime, only 65 percent received routine screening within the recommended one to two year interval. The remaining 35 percent had one or two screening mammograms and did not return with 27 months.

The figures only address the need for a critical evaluation regarding the issue as to why women fail to report. An initiative by the breast cancer registry to follow up patients on a long-term basis would be appropriate.


'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patient’s perception of health status helps in better recover
7. Patients often assume wrongly that they are allergic to penicillin
8. New FDA Approved Drug NATRECOR For Heart Failure Patients
9. Hemochromatosis Patients Blood is Safe
10. Fifth US Patient Receives Artificial Heart
11. Patients Pressure Would Result In Overprescription
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... San Diego, CA (PRWEB) , ... March 28, 2017 , ... ... and turtlenecks from the daily wardrobe. However, for those self-conscious about a double chin, ... believe they have the ideal solution. , “For most people, a double chin ...
(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology , ... biometric time and attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based ... Attendance uses biometric face recognition to enable users to check in and out ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin ... one of few medical professionals in the country to sit on the 2017 National ... Aesthetics, in just 2 years Dr. Harper helped propel the clinic from a small ...
(Date:3/28/2017)... Atlantic City, NJ (PRWEB) , ... March 28, ... ... annual American Camp Association’s Tri-State Camp Conference in Atlantic City March 13-16, was ... partners, and their team of professional staff discussed strategies for preventing outbreaks among ...
(Date:3/28/2017)... St. Louis, MO (PRWEB) , ... March 28, ... ... high levels of job satisfaction in their profession as their value increases in ... a company that provides resources such as job boards, career fairs, and candidate ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... United Kingdom and  BOSTON , March 28, ... Linguamatics today announced a partnership with ... The agreement allows pharmaceutical companies to extract key ... I2E text mining technology. The ... of the top 20 global pharmaceutical companies. The ...
(Date:3/28/2017)... , March 28, 2017  AcelRx Pharmaceuticals, Inc. ... the development and commercialization of innovative therapies for ... the European Medicines Agency (EMA) has notified the ... mcg) Marketing Authorisation Application (MAA) has passed validation, ... is underway. The MAA for ARX-04 (known as ...
(Date:3/28/2017)... 28, 2017 The global ... 8.0 billion by 2025, according to a new study ... infectious diseases and cancer is expected to upsurge the ... over the coming years. In addition, higher number of ... allogenic stem cell therapy, due to adverse effects caused ...
Breaking Medicine Technology: